Europe - April 2017

• Europe: Latest timings on the new Regulations for medical devices and IVDs

• Europe: Products whose principal intended action (depending on PAC present in cranberry) is to prevent or treat cystitis, should not be medical devices

• Europe: Joint Action on Market Surveillance of Medical Devices launched at 39th CAMD meeting

• Europe: Eucomed and EDMA formally merge to create MedTech Europe

• France: Advice for French manufacturers if their Notified Bodies cease operations

• Sweden: Responsibility for Notified Bodies to transfer to MPA from SWEDAC

• Switzerland: Grace period for manufacturers affected by the de-designation of their Notified Body

• UK: Significant fee increases proposed by MHRA to aid cost recovery

Click here for the full article on Global Regulatory Press.

Contact us at info@arq-on.com.